Using rhodamine efflux assay on NCI/ADR-RES cancer cells, SECO was confirmed as a P-gp inhibitor, where cells treated with 25 or 50 μM of SECO showed significantly higher fluorescence intensity compared to control. This evidence concerns the gene PGP and cancer.